SOD activity was increased in all breast cancer subtypes, but the maximum increase in SOD activity was observed in the luminal B(+) subtype (+56.8%, p = 0.0099), which correlates with the maximum decrease in catalase activity in this subgroup (Figure 2). The gene discussed is SOD1; the disease is breast carcinoma.